Intervention trials for prevention of metabolic dysfunction among patients with schizophrenia

Intervention trials for prevention of metabolic dysfunction among patients with schizophrenia - Intervention trials for prevention of metabolic dysfunction among patients with schizophrenia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014016

Enrollment

540

Registered

2014-06-01

Start date

2014-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome among patints with schizophrenia

Interventions

No intervention Weigt check at every visit Weigt check at every visit, and nutrition education

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Subjects are required to be stabilised and treated with an antipsychotic drug for at least three months. (2) Subjects have BMI greater than or equal to 25. Or subjects have waist circumference greater than or equal to 90cm in males and 80cm in females.

Exclusion criteria

Exclusion criteria: (1) Subjects have eating disorder, mental retardation and alcohol or substance dependence syndrome. (2) Subjects under treatment or nutrition education for diabetes. (3) Subjects were provided nutrition education during past 1 year

Design outcomes

Primary

Measure	Time frame
Incidence of metabolic syndrome during 1 year	—

Secondary

Measure	Time frame
Weight change during 1 year	—

Countries

Japan

Contacts

Public ContactMikiko Kitahara

Japan Psychiatric Hospitals Association Secretariat

m-kitahara@nisseikyo.or.jp03-5232-3311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026